Inari Medical has signed on to a $415 million deal to acquire LimFlow, just weeks after the company received an FDA approval for its minimally invasive approach to re-establish oxygenated blood flow ...
PARIS & SAN JOSE, Calif.--(BUSINESS WIRE)-- LimFlow SA, a pioneer in the development of minimally-invasive technology for the treatment of chronic limb-threatening ischemia (CLTI), a severe form of ...
IRVINE, Calif., Jan. 08, 2021 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a commercial-stage medical device company focused on developing products to treat and transform the lives ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results